πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

AstraZeneca Pipeline

All ClinicalTrials.gov programs at AstraZeneca β€” phase, modality, and trial IDs.

Programs
92

Quick answer

AstraZeneca has 92 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. AZD0780

    AstraZeneca

    Heterozygous Familial Hypercholesterolaemia

    phase 3 small molecule active

    1 trial

  2. AZD0780

    AstraZeneca

    Cardiovascular Disease

    phase 3 small molecule active

    1 trial

  3. AZD0901

    AstraZeneca

    Gastric Cancer

    phase 3 small molecule active

    2 trials

  4. AZD9291 80 mg/40 mg

    AstraZeneca

    Stage IB-IIIA Non-small Cell Lung Carcinoma

    phase 3 small molecule active

    1 trial

  5. Acalabrutinib

    AstraZeneca

    Untreated Chronic Lymphocytic Leukemia

    phase 3 small molecule active

    1 trial

  6. Aclidinium bromide/formoterol Fixed-Dose Combination

    AstraZeneca

    COPD

    phase 3 small molecule completed

    1 trial

  7. Aclidinium bromide/formoterol Fixed-Dose Combination (FDC)

    AstraZeneca

    Chronic Obstructive Pulmonary Disease

    phase 3 small molecule completed

    1 trial

  8. Anifrolumab

    AstraZeneca

    Active Systemic Lupus Erythematosus

    phase 3 mab completed

    3 trials

  9. Anifrolumab

    AstraZeneca

    Cutaneous Lupus Erythematosus

    phase 3 other active

    1 trial

  10. Anifrolumab

    AstraZeneca

    Lupus Nephritis

    phase 3 small molecule active

    1 trial

  11. Anifrolumab

    AstraZeneca

    Systemic Lupus Erythematosus

    phase 3 mab active

    1 trial

  12. BGF MDI 320/14.4/9.6 ΞΌg

    AstraZeneca

    COPD (Chronic Obstructive Pulmonary Disease)

    phase 3 small molecule active

    1 trial

  13. BGF MDI 320/28.8/9.6 ΞΌg

    AstraZeneca

    Asthma

    phase 3 small molecule completed

    1 trial

  14. BGF MDI HFO 320/14.4/9.6ΞΌg

    AstraZeneca

    COPD (Chronic Obstructive Pulmonary Disease)

    phase 3 small molecule completed

    1 trial

  15. Baxdrostat

    AstraZeneca

    Primary Hyperaldosteronism

    phase 3 small molecule active

    1 trial

  16. Baxdrostat

    AstraZeneca

    Uncontrolled Hypertension

    phase 3 small molecule completed

    2 trials

  17. Benralizumab

    AstraZeneca

    Chronic Obstructive Pulmonary Disease

    phase 3 mab completed

    1 trial

  18. Benralizumab

    AstraZeneca

    Asthma

    phase 3 mab completed

    1 trial

  19. Benralizumab 30 mg

    AstraZeneca

    Nasal Polyposis

    phase 3 mab terminated

    1 trial

  20. Budesonide

    AstraZeneca

    Asthma

    phase 3 small molecule completed

    1 trial

  21. Budesonide/formoterol Turbuhaler

    AstraZeneca

    Asthma

    phase 3 small molecule completed

    1 trial

  22. Capivasertib

    AstraZeneca

    Triple Negative Breast Neoplasms

    phase 3 small molecule active

    1 trial

  23. Cediranib

    AstraZeneca

    Colorectal Cancer

    phase 3 small molecule completed

    1 trial

  24. Cediranib

    AstraZeneca

    Recurrent Glioblastoma

    phase 3 small molecule completed

    1 trial

  25. Dapagliflozin

    AstraZeneca

    Type 2 Diabetes Mellitus

    phase 3 small molecule completed

    2 trials

  26. Dapagliflozin

    AstraZeneca

    Heart Failure With Preserved Ejection Fraction (HFpEF)

    phase 3 small molecule completed

    1 trial

  27. Dapagliflozin

    AstraZeneca

    Chronic Heart Failure With Reduced Ejection Fraction (HFrEF)

    phase 3 small molecule completed

    1 trial

  28. Dapagliflozin

    AstraZeneca

    Heart Failure With Preserved Ejection Fraction

    phase 3 small molecule completed

    1 trial

  29. Dapagliflozin

    AstraZeneca

    Type 2 Diabetes

    phase 3 small molecule completed

    3 trials

  30. Dapagliflozin 10 mg

    AstraZeneca

    Diabetes Mellitus, Non-Insulin-Dependent

    phase 3 small molecule completed

    1 trial

  31. Dapagliflozin 10 mg

    AstraZeneca

    Type 2 Diabetes Mellitus

    phase 3 small molecule terminated

    1 trial

  32. Dato-DXd

    AstraZeneca

    Breast Cancer

    phase 3 small molecule active

    2 trials

  33. Docetaxel

    AstraZeneca

    Prostate Cancer

    phase 3 small molecule completed

    1 trial

  34. Durvalumab

    AstraZeneca

    Non-Small Cell Lung Cancer

    phase 3 small molecule active

    2 trials

  35. Durvalumab

    AstraZeneca

    Hepatocellular Carcinoma

    phase 3 small molecule active

    2 trials

  36. Durvalumab

    AstraZeneca

    Carcinoma, Non-Small-Cell Lung

    phase 3 small molecule active

    1 trial

  37. Durvalumab

    AstraZeneca

    Advanced Hepatocellular Carcinoma

    phase 3 small molecule active

    1 trial

  38. Durvalumab

    AstraZeneca

    Cancer

    phase 3 small molecule active

    1 trial

  39. Durvalumab

    AstraZeneca

    Locally Advanced Cervical Cancer

    phase 3 mab completed

    1 trial

  40. Durvalumab

    AstraZeneca

    Muscle Invasive Bladder Cancer

    phase 3 small molecule active

    1 trial

  41. Durvalumab

    AstraZeneca

    Non Small Cell Lung Cancer NSCLC

    phase 3 small molecule active

    1 trial

  42. Durvalumab + SoC chemotherapy

    AstraZeneca

    Carcinoma, Non-Small-Cell Lung

    phase 3 small molecule completed

    1 trial

  43. Experimental: Tezepelumab

    AstraZeneca

    Asthma

    phase 3 mab completed

    1 trial

  44. Gefitinib

    AstraZeneca

    Non-Small-Cell Lung Carcinoma

    phase 3 small molecule completed

    1 trial

  45. Gefitinib

    AstraZeneca

    NSCLC

    phase 3 small molecule completed

    1 trial

  46. Gemcitabine

    AstraZeneca

    Biliary Tract Cancer

    phase 3 small molecule active

    1 trial

  47. IMFINZI 50 mg/mL concentrate for solution for infusion.

    AstraZeneca

    small cell lung cancer

    phase 3 small molecule active

    1 trial

  48. MEDI4736

    AstraZeneca

    Squamous Cell Carcinoma of the Head and Neck

    phase 3 mab completed

    1 trial

Frequently asked questions

How many pipeline programs does AstraZeneca have?

92 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.